Market cap
$701m
Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.
Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.
Our revenues are generated primarily through our collaborative arrangements and license agreements related to research and development and commercialization of linaclotide. The majority of our revenues are generated from the sales of LINZESS in the U.S. Although we expect net sales to increase over time, the settlement payments between AbbVie and us, resulting in collaborative arrangements revenue or collaboration expense, are subject to fluctuation based on the ratio of selling, general and administrative expenses incurred by each party. …IRONWOOD PHARMACEUTICALS INC, 10-Q, period ended 2026-06-30, filed 2026-08-06